Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

Dr. Christopher J. Sayed shares insights on the growing emphasis on personalized care for hidradenitis suppurativa.

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...

The Protein Society, the premier international society dedicated to supporting protein research, announces the winners of the 2025 Protein Society Awards, which will be recognized  at the 39th Annual ...

Nanobodies are smaller than conventional monoclonal antibodies and, according to their developers, can offer greater stability, higher potency, and lower production or synthesis costs. Sanofi's ...

We envisioned our method contributing toward the goal of fast 3D multitarget super-resolution imaging. 1 mM His-tag containing nanobodies was cleaved by 0.6 μM bdNEDP1 protease in a thermoshaker at 20 ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication ...